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One of the landmark events of the past 25 years in neuroscience research was the establishment of neural
stem cells (NSCs) as a life-long source of neurons and glia, a concept that shattered the dogma that the
nervous system lacked regenerative power. Stem cells afford the plasticity to generate, repair, and change
nervous system function. Combined with reprogramming technology, human somatic cell-derived NSCs
and their progeny can model neurological diseases with improved accuracy. As technology advances, we
anticipate further important discoveries and novel therapies based on the knowledge and application of
these powerful cells.Introduction
It is an understatement to say that the conceptual advances and
practical applications of stem cell research have been game
changers for the field of neuroscience. When the term ‘‘stem
cell’’ was used 25 years ago, the context was typically adult
tissue homeostasis, mouse genetics, or early development.
Thanks to several landmark advances in the area of develop-
mental neurobiology, neural stem cells (NSCs) are now central
to our discussion of how the brain forms. While there was evi-
dence for adult neurogenesis early on, it was controversial,
and the underlying cells responsible for continued neuronal
and glial production were not characterized. Today it would be
difficult to consider adult neurogenesis without reference to
endogenous NSCs and their niches. Although early researchers
had determined that individual transcription factors directed cell
fate, as in MyoD for muscle, and had done pioneering experi-
ments proving that oocyte proteins could dedifferentiate a
somatic cell nucleus, they could not have imagined the explosion
of reprogramming that now allows us to generate human neural
cells from induced stem cells and enables us to model nervous
system diseases in entirely new ways. Progress at the basic
research level has also been astonishing, andwe are already wit-
nessing the translation of NSC science, with several clinical trials
ongoing and more in the planning stages.
In the following Perspective, we will review some of the mile-
stones of the last 25 years in NSC research. Rather than
providing a comprehensive review of these advances, we intend
to highlight the major events and discoveries that we feel have
made the most important contributions to our field. In particular,
we will focus on the shifts in the field around the concept of adult
neurogenesis and stem cells in the adult brain, especially in the
hippocampus. We will discuss the more recent development of
methodologies for reprogramming and induced pluripotent
stem cells (iPSCs) and outline our views on the promise of
NSC-based approaches for the treatment of disease. Significant
milestone advances that have driven NSC research forward have
been summarized in Table 1, and we have also provided a tools
wish list that would enable researchers to address some key588 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.remaining questions concerning NSC biology (Table 2). The
views here represent our personal perspectives on what has
been particularly significant; we readily acknowledge that this
only reflects a fraction of the interesting and important work in
the field, and we apologize to those whose work we have not
had space to discuss and reference. As you read this Perspec-
tive, we hope to inspire you to imagine the conceptual advances
and new applications of NSC research over the next 25 years.
I. Early Halcyon Days for Studies on the Development of
the Nervous System
It is difficult to imagine how much in the dark we were about
mammalian nervous system development back in the 1980s.
One of the burning questions at that time was whether or not
common progenitor cells for neurons and glia even existed.
Stem cells were not generally considered a part of brain develop-
ment but rather the building blocks of other, more plastic tissues.
The tools available to us to address these fundamental questions
were limited. In vivo studies of the developing brain relied heavily
on histological stains that would have been familiar to Camillo
Golgi, in vitro culture media were primitive, growth factors to
stimulate division of neural progenitors had not been identified,
and there were only a handful of antibodies to identify neural
cell types. But we were young researchers in a young field,
excited by the questions, undaunted by the challenges, and
fortunate to be on hand at the beginning of arguably the most
extraordinarily productive quarter century in developmental
neuroscience.
Identifying the Progeny of Single Cells Revealed
Heterogeneous Progenitor Cells, Including NSCs
As is often the case in developmental studies, invertebrate
research had taken the lead, and methods to genetically mark
individual progenitor cells in vivo revealed unexpected clonal
boundaries and patterns that revolutionized our comprehension
of how insects are built. With this inspiration, the question
was how to look into the developing CNS of large, cytologically
complex, opaque organisms that inconveniently developed in
utero. The door was opened by the development of retroviral
Neuron
Perspectivelineage-tracing methods applicable to mammals. In the mouse
cerebral cortex, for example, these techniques showed that
most progenitor cells at midgestation generated surprisingly
small clones, typically solely of neurons, that could migrate quite
widely (Price and Thurlow, 1988; Turner and Cepko, 1987; Walsh
and Cepko, 1992). Earlier infected clones could span multiple
cortical layers, indicating multipotency for neuronal production
(Kornack and Rakic, 1995). We learned that mixed neuron-glia
cloneswere rare in the cortex but far more numerous in the spinal
cord, where clones containing motor neurons, interneurons, and
glial progeny were observed (Leber and Sanes, 1995).
To determine whether the diversity of clones seen in vivo re-
flected environmental cues that the clonal progeny encountered
or cell-intrinsic heterogeneity, researchers began to perform
clonal studies in vitro, observing single embryonic cells growing
in a standardized environment to uncover cell-based differ-
ences. Most embryonic progenitors produced clones of solely
neurons, others of solely glia, but, most excitingly, a small subset
of progenitors had large proliferative potential and incontrovert-
ibly produced both neuronal and glial progeny. These progeni-
tors also demonstrated some capacity for self-renewal, a
cardinal property of stem cells (Anderson, 1989; Cattaneo and
McKay, 1990; Davis and Temple, 1994; Kilpatrick and Bartlett,
1993; Temple, 1989). These discoveries led to the concept that
nervous system development, both peripheral and central, was
similar to that of the blood system and relied on fundamental,
multipotent NSCs that repeatedly producedmore restricted neu-
ral progenitors that, in turn, divided just a few times to produce
small numbers of differentiated progeny.
Today, while studies of progenitor heterogeneity are advanc-
ing—for example, by the identification, within germinal zones,
of cells with diverse morphologies and diverse markers (Ayoub
et al., 2011; Fietz et al., 2012; Franco et al., 2012; Kawaguchi
et al., 2008; Pinto et al., 2008)—embryonic neural progenitor
cells (NPCs) are still classified into just two basic types: multipo-
tent NSCs and transit amplifying/intermediate progenitor cells
(IPCs) (Englund et al., 2005). We have yet to define most of the
progenitor subsets contributing the vast array of fates seen clon-
ally in vivo and in vitro and to understand their key regulators and
their role in neural development. These will be significant goals
for the next decade.
Uncovering the Dynamics of NSC Behavior
Development can be thought of as increasing cellular complexity
over time. We marvel at the precise orchestration of cell prolifer-
ation and then differentiation into innumerable types of neurons
and then glia. How are these events choreographed? Pioneering
heterochronic transplantation studies demonstrated that early
progenitors have a wide multipotency but late progenitors are
unable to produce the earlier fates (Frantz and McConnell,
1996; McConnell and Kaznowski, 1991). This finding led to a
key idea that the potential of CNS stem cells is progressively,
temporally restricted.
How do CNS progenitor cells change over time? The develop-
ment of tools to record extended time-lapse movies of CNS
germinal cells ex vivo has yielded enormous insights. Movies
of isolated cortical clones growing in 2D cultures showed that
the lineage trees of isolated murine CNS progenitor cells were
highly reminiscent of those of invertebrates and, astonishingly,that individual cells were programmed to recapitulate the timing
of diverse progeny seen in vivo, including their gradual restriction
in potency (Shen et al., 2006). Combining retroviral labeling and
slice culture, we could observe cortical progenitor cells in a sys-
tem that retained much of the normal 3D niche architecture. This
technique revealed that radial glial cells (RGCs), which span from
their soma in the ventricular zone (VZ) to the pial surface, were
the fundamental progenitor cells for neurons (Noctor et al.,
2001) and later glia. Combined with in vitro studies using trans-
genic reporters for RGCs (Malatesta et al., 2000), this finding
led to the notion that embryonic multipotent CNS NSCs were a
subset of RGCs. The advancement of sophisticated imaging
techniques and analytical tools (Winter et al., 2011) has great po-
tential to further illuminate progenitor cell behavior over time. We
look forward to observing multiple signals simultaneously,
enabling us to follow the expression and movements of not
only single genes or proteins but also of pathways and networks,
as the progenitor cells change during neural development and
after challenges.
Much progress has been made to understand the temporal
control of NSC output. Steps in the timing process rely on pro-
duction of gliogenic cues, such as cardiotropin, transcription
factor sequences, DNA methylation changes, and chromatin
modifications (Barnabe´-Heider et al., 2005; Hirabayashi et al.,
2009; Namihira et al., 2009; Pereira et al., 2010). Yet today, key
aspects of the mechanisms that underlie progenitor temporal
control remain enigmatic, presenting a challenge that is some-
what ahead of the tools currently available. We need the means
to rapidly record dynamic changes in multigene expression,
transcription factor binding, and chromatin structure and,
ideally, to do so within living progenitor cells as they divide and
move down the lineage trees. It is a lot to ask but, given the rapid
evolution of single-cell tools, we might get there sooner than
expected.
How Are CNS Stem Cells Regionally Patterned?
One of the central discoveries in developmental neuroscience
that has emerged in this past 25-year era concerns how the ner-
vous system is regionally patterned. Embryological manipula-
tions—first in chick, then with transgenic mice—elucidated the
morphogenic gradients that pattern neural tissue, for example,
ensuring that motor neurons and oligodendrocytes arise
ventrally and interneurons arise dorsally in the spinal cord (Bris-
coe et al., 1999; Liem et al., 1997). Other notable studies re-
vealed that specific CNS regions can be organizers; for example,
the midhindbrain isthmus drives midbrain patterning via release
of FGF8, so that implanted beads containing FGF8 cause dupli-
cation of the cerebellum (Martinez et al., 1999). Studies of mouse
mutants that were almost perfect apart from the lack of specific
brain regions showed that the CNS develops asmodules defined
by transcription factor domains (Puelles and Rubenstein, 2003).
One fascinating question that we have yet to answer is how
morphogenic gradients intersect with and activate specific line-
age programs in NSCs and their progeny, so that discrete,
regionally appropriate progeny are made.
While CNS development is modular, cells can cross regional
boundaries. In a landmark demonstration, GABAergic neurons
in the forebrain were shown to be born ventrally and migrate
into the overlying dorsal cortex (Anderson et al., 1997). ThisNeuron 80, October 30, 2013 ª2013 Elsevier Inc. 589
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Perspectivefinding—that almost the entire inhibitory neuron complement of
the cortex arose from NSCs that were born elsewhere—was
most surprising. Migration was not just along radial glia but
tangential (O’Rourke et al., 1995), and the routes of all sorts of
peripatetic CNS progenitor cells have now been revealed, from
the pioneering Cajal-Retsius neurons from the cortical hem
(Bielle et al., 2005) to the vast spreading migrations of different
waves of oligodendrocyte precursors (Kessaris et al., 2006;
Timsit et al., 1995). Such mixing increases the richness of con-
nective possibilities, and cell migratory defects will continue to
be explored as the cause of multiple neurological disorders.
Building the Foundation of Human NSC Studies
Much of our understanding of mammalian neural development
comes from mouse studies, and resources such as BGEM,
Genepaint, the Allen Brain Atlas, MGI, and KOMP enable us to
question further and deeper. Still, the mouse is lissencephalic,
its neuronal complement is born in essentially 7 days, and no
one doubts comparative studies that indicate significant differ-
ences in how the 1,000-fold larger human brain is built over
9 months of gestation (Zeng et al., 2012). But, thanks to vast
improvements in tools and resources and to the advent of human
stem cell biology, we are now ready to take on the task of under-
standing human CNS development. The next 25 years, we pre-
dict, will witness great strides in that area. Already, we know
that the human forebrain has not just the VZ and subventricular
zone (SVZ) but also a significantly expanded germinal zone,
the outer SVZ, which helps account for the orders of magnitude
increase in its size and complexity (Bystron et al., 2008; Hansen
et al., 2010). Dissection of these germinal layers provides a clue
to the key transcription factors and pathways that characterize
their constituent cells (Fietz et al., 2012). In the future, funda-
mental molecular studies will expand our knowledge of the tem-
poral patterns of gene expression and epigenomic changes that
accompany human neural development (Kang et al., 2011). New
techniques for creating in vitro human neural organoids with
salient morphologic features such as retinal and cortical layering
(Aoki et al., 2009; Eiraku et al., 2011; Lancaster et al., 2013;
Meyer et al., 2011) will enable 3D imaging of how human CNS
progenitor cells work and will broaden our understanding of
CNS morphogenesis.
Progress over the past 25 years in characterizing embryonic
NSCs and understanding their patterning, lineages, and role in
nervous system development has been and continues to be
complemented by tremendous strides in the characterization
of adult NSCs, enabling cross-fertilization of ideas and tools
and encompassing adult learning and memory, environmental
regulation, cancer, and aging.
II. Discovery and Elaboration of Adult NSCs and
Neurogenesis
History: Cell Division to Neurogenesis in the Adult Brain
The observations of cell division and differentiation in the adult
brain emerged from studies of brain development and were
greatly advanced by the early application by Leblond and col-
leagues of tritiated thymidine, which incorporates into the DNA
of dividing cells and can be detected by autoradiography. Using
this labeling technique, Leblond and colleagues observed and
concluded that glial cells were probably dividing throughoutNeuron 80, October 30, 2013 ª2013 Elsevier Inc. 591
Table 2. Wish List of Technologies that Will Accelerate or Enable Important Directions in NSC Research
Tool Questions Translation
More antibody and other markers
to prospectively identify NSCs and
NPCs
What is the range of types of
NSCs and NPC present in mouse
and human?
Understanding the contribution
of NSC lineages to disease
Diverse fluorescent markers to report
multiple genes, multiple proteins
Visualize complex elements in
the same cell
Broad multiplex imaging: for
immunostaining, in situ and gene
expression reporting
To track multiple molecules
simultaneously—analysis of
networks, pathways and
multimolecular complexes
How do NSC pathways
change during development
and with aging?
3D cultures that recapitulate human
neural development; integrate
engineering
What mechanisms underlie human
NSC development into neural
progeny?
What morphologic changes
accompany CNS
development?
Improved cell transplants and
prostheses and disease models
More 2D and 3D imaging and
analysis tools ex vivo
How do NSCs interact with niche
cells, statically and dynamically?
Quantification of image
information
Imaging standards for cell
products; pathology assessment
High definition (deeper and higher
resolution), in vivo imaging
What is the dynamic behavior of
NSCs in vivo in the normal niche?
How do NSCs migrate and
integrate in vivo?
Precise cell tracking after
transplantation in vivo
Closer collaborations between
basic, clinical, applied, and
commercial stake holders
What are the clinical implications
of NSC-based discoveries?
Critical for effective translation
Better nonviral transfection
methods
Accelerate and reduce the cost
of answering many questions
about NSCs
Allow easy, high-throughput
screening
Improved models of neurological
disease
What is the disease mechanism? What pathways are best
targeted?
Could supplant animal models for
efficacy and some tox studies
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Perspectivethe parenchyma (Smart and Leblond, 1961). They specifically
found dividing cells in the subependymal zone (SEZ) but did
not observe neurogenesis because the percursors born in the
SEZ, later renamed the SVZ, must migrate to the olfactory bulb
before they differentiate into neurons. Soon after these pioneer-
ing studies, Joe Altman, using the same techniques, observed
dividing cells in the subgranular zone and speculated that neuro-
genesis occurred in the adult rat and cat dentate gyrus (DG) (Alt-
man, 1962, 1963). Then, in 1965, he and Gopal Das provided the
first strong evidence for neurogenesis in the adult brain (Altman
and Das, 1965), reporting on themigration of cells that were born
postnatally in the SVZ and matured into neurons in the olfactory
bulb. In 1969, Altman was the first to describe the rostral migra-
tory stream, located between the SVZ and olfactory bulb (Alt-
man, 1969). Surprisingly, there was little follow-up to these
discoveries for almost 10 years, when Kaplan and Hinds pro-
vided electron microscopic data, combined with tritiated thymi-
dine staining, that showed the existence of adult-born neurons in
the DG and the olfactory bulb (Kaplan and Hinds, 1977). The next
phase in the early history of adult neurogenesis moved to the
avian brain, where Goldman and Nottebohm first detected
what they reported was neurogenesis in adult birds (Goldman
and Nottebohm, 1983); Paton and Nottebohm then demon-
strated functionality by unit recording and then autoradiography
of thymidine-labeled neurons (Paton and Nottebohm, 1984).
After another period of little activity in the area, four develop-
ments and discoveries changed the perception of neurogenesis
in the mammalian brain in the 1990s. The first was the observa-
tion that proliferation levels of the early progenitor cells and sub-
sequent numbers of newborn neurons were regulated. Gould,592 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.Cameron, and McEwen demonstrated that stress levels nega-
tively affected the numbers of proliferating cells in the DG (Gould
et al., 1992). This findingwas followed by a series of observations
demonstrating that neurogenesis could be substantially in-
creased by running (van Praag et al., 1999), that housing animals
even for short periods of enrichment in complex environments
increased robustly the number of surviving newborn neurons
(Kempermann et al., 1997), that learning itself could influence
adult neurogenesis (Do¨bro¨ssy et al., 2003; Gould et al., 1997),
and that antidepressant drugs (SSRIs) as well as alcohol (Nixon
and Crews, 2002) could influence components of the adult neu-
rogenesis process (Malberg et al., 2000). Around this same time,
neurogenesis was shown to decrease with age but persist
throughout life (Kuhn et al., 1996).
A second development was the advancements in immunohis-
tological techniques, combined with the application of confocal
microscopy to the study of adult neurogenesis and, importantly,
the application of stereological techniques for labeling dividing
cells (in particular bromodeoxyuridene [BrdU]) and neurons
(initially NeuN). These techniques allowed the simultaneous
colabeling of neurons and proliferating cells and quantification
of the changes in these cells in vivo, convincingly demonstrating
that the dividing cells in the DG indeed became neurons (Kem-
permann et al., 1997; Kuhn et al., 1996, 1997). Using these
techniques combined with transplantation, Lois and Alvarez-
Buylla demonstrated that endogenous and engrafted SVZ cells
migrated into the olfactory bulb (Lois and Alvarez-Buylla,
1994). They also provided evidence for the surprising finding
that stem cells in the adult SVZ expressed the astrocyte marker
GFAP (Doetsch et al., 1999).
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newly applied techniques to identify new neurons in the DG
of cancer patients who were given BrdU for diagnostic pur-
poses (Eriksson et al., 1998), generalizing the findings of adult
neurogenesis to humans. This demonstration of human adult
neurogenesis was confirmed recently using carbon14 dating
techniques on neurons derived from individuals born during
the period of above-ground nuclear testing (Spalding et al.,
2013).
The fourth important development was the identification of
methods to isolate, propagate, and differentiate progenitors
from the adult CNS in defined culture conditions. This break-
through was first achieved from dissections of the lateral wall
of the striatum to obtain cells of the SVZ and then the expansion
of the proliferating population into what came to be known
as neurospheres (Kilpatrick and Bartlett, 1993; Reynolds and
Weiss, 1992). The subgranular zone (SGZ) population of dividing
cells was isolated from the hippocampus and then expanded
in vitro and maintained as monolayers (Palmer et al., 1995,
1997). The ability to isolate, maintain, expand, and differentiate
these precursor cells in vitro led to the ability to explore, in
more detail, the cellular and molecular nature of the cells and
the mechanisms that regulated their behavior. The in vitro cells
could then be tested in vivo using the newly developed in vivo
tools. The demonstration of neurogenesis in humans, along
with its regulation by behavior and the environment, highlighted
its relevance to the scientific community and helped motivate
research into the wider regenerative potential of NSCs.
The Niche
Over the ensuing decade (2000–2010), many of the details of the
phenomenon of neurogenesis were revealed. Importantly, the
anatomical location and cellular constituents of the ‘‘niche’’
where NSCs are born and maintained were found to be more
complex than anticipated but to be similar to niches that were
being discovered for stem cells generated in other adult organs.
The phenomenon of neurogenesis can be delineated into
four processes: cell proliferation, migration, cell survival, and
neuronal differentiation. Each aspect is critical to the overall
levels of neurogenesis. For example, NPC proliferation occurs
in other regions of the adult brain but NPCs do not differentiate
into neurons there, either maintaining the properties of precur-
sors or becoming glia. However, NPCs isolated from these non-
neurogenic regions, such as cortex and optic nerve, in the adult
brain retain the potential to become neurons in vitro when
expanded in FGF-2 and treated with differentiating molecules
like retinoic acid and Forskolin, indicating that extrinsic factors
play amajor role in stimulating NPCs to differentiate into neurons
(Palmer et al., 1999). Additional support for the importance of the
neurogenic microenvironment comes from the finding that NPCs
located in the SVZ and SGZ are the only ones that adopt a
neuronal cell fate under normal physiological conditions in the
adult brain; however, if these NPCs are isolated from the SVZ
or GVZ with the techniques described above and then trans-
planted into ectopic regions of the adult brain, they differentiate
mostly to oligodendrocytes and astrocytes (Seidenfaden et al.,
2006). In contrast, NPCs from the DG can differentiate into olfac-
tory bulb neurons when grafted to the SVZ (Suhonen et al., 1996)
and, more dramatically, NPCs isolated from a nonneurogenic re-gion, such as the spinal cord, can differentiate into neurons when
transplanted into the DG, supporting the idea that external cues
from the local microenvironment promote the neuronal differen-
tiation of NPCs (Shihabuddin et al., 2000).
The SVZ and SGZ represent neurogenic niches or local micro-
environments that permit and support neurogenesis. To date,
many of the cellular constituents of the niche have been identi-
fied, including astrocytes (Song et al., 2002b), endothelial cells
(Shen et al., 2004), microglia (Sierra et al., 2010), and the blood
vascular system itself (Palmer et al., 2000). A more complete
understanding of the molecules and events that regulate the
niche and its influence on neural stem cell behavior is being
revealed on a daily basis in the current literature. What will be
very useful—and has not yet been achieved because of the
optical limits—is the observation in real time of stem cells in their
niche and the temporal process by which the cells interact with
their microenvironment to generate neurons.
Morphological Transition of Stem Cells to Neurons
New neurons born in the adult brain undergo a maturation pro-
cess that takes several months before they are essentially equiv-
alent to mature neurons. Arising from a local stem cell population
(Gage, 2000), adult-born neurons initially are not directly con-
nected at all to local circuitry. Nonetheless, they are apparently
responsive to local neurotransmitters, likely through spillover
from nearby synapses (Song et al., 2002a). It takes about
2 months for newborn neurons to reach morphological maturity.
Although no significant structural differences are observed
between fully mature adult-born and perinatal-born neurons,
the maturation process is delayed in the adult (Zhao et al.,
2006), and it is very likely that this delay is crucial for their func-
tion both as young neurons and subsequently asmature neurons
(Aimone et al., 2009). Notably, the spine formation process of
adult-born neurons appears to be different from that of peri-
natal-born neurons in that adult-born neurons preferentially
target pre-existing synapses; little is known about the underlying
mechanisms (Toni et al., 2007). One hypothesis is that glutamate
spillover may play a chemoattractive role and induce filopodia
growth toward active synapses (Toni and Sultan, 2011; Toni
et al., 2007). Local synaptic activity may induce glutamate
release and activate glutamate receptors in filopodia, which
induces new filopodia to target the existing synapse (Toni and
Sultan, 2011).
This structural difference parallels the differences between the
physiologies of immature and mature granule cells. Newborn
neurons display a high input resistance (Espo´sito et al., 2005),
receive less inhibition (Li et al., 2012), and have been shown to
exhibit considerably greater synaptic plasticity than mature
granular neurons (Ge et al., 2007; Schmidt-Hieber et al., 2004).
Days after newborn neuron birth, these cells respond to ambient
GABA with tonic activation, due to the high concentration of
intracellular chloride that leads to depolarization (Espo´sito
et al., 2005; Ge et al., 2007). In 1–2 weeks, newborn neurons
begin to receive synaptic GABAergic input. After 2–3 weeks,
they begin to express glutamatergic receptors and, soon after,
the direction of the chloride gradient switches such that
GABAergic input results in hyperpolarization of newborn neurons
(Espo´sito et al., 2005; Ge et al., 2007; Marı´n-Burgin et al., 2012).
Around 1 month, new neurons receive synaptic glutamatergicNeuron 80, October 30, 2013 ª2013 Elsevier Inc. 593
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pande et al., 2013; Li et al., 2012; Toni et al., 2007; Vivar et al.,
2012). However, at this time point, new neurons have a lower
density of GABA inputs and inhibitory postsynaptic currents
(IPSCs) compared to those in mature granule neurons (Espo´sito
et al., 2005; Li et al., 2012; Marı´n-Burgin et al., 2012). Once fully
mature (about 8 weeks after birth), newborn neurons are essen-
tially indistinguishable physiologically from developmentally
born granule neurons.
Because of these unique properties, young neurons are likely
to be more excitable than mature neurons (Espo´sito et al., 2005;
Mongiat et al., 2009; Mongiat and Schinder, 2011) and thus,
in response to presynaptic inputs, the synapses formed by
newborn neurons in the multisynapse boutons may be more dy-
namic than the existing synapses, contributing to the unique
function of adult neurogenesis. There are still important aspects
of this process that remain unknown, and a more complete
understanding is critical to determining the influence of young
neurons on the broader hippocampal circuit, as they are likely
critical for both feedforward (to the CA3) and feedback (to the
DG) inhibition.
Functional Significance for Adult Neurogenesis
Once the evidence for the existence of adult neurogenesis was
generally accepted, the question of its functional relevance
emerged. A series of correlational studies clearly revealed that
increasing neurogenesis in the DG increased behavioral per-
formance in a variety of hippocampus-related tasks and,
conversely, decreasing neurogenesis resulted in behavioral
impairments. Experiments designed to decrease neurogenesis
by irradiation, viruses, antimitotic agents, or engineering trans-
genic animals whose adult neurogenesis could be regulated
genetically or pharmacologically all confirmed a functional role
for adult neurogenesis in the DG (Deng et al., 2010). To more
completely understand the functional importance of adult neuro-
genesis, it is important to consider adult neurogenesis in the
context of the hippocampus and its theoretical function as a
whole.
Individual GCs in the DG receive inputs from thousands of
entorhinal cortex neurons, suggesting that they are capable of
representing a highly complex combination of spatial and object
features simultaneously. Several studies have suggested that
the DG’s encoding role can be thought of in this fashion (Morris
et al., 2013; O’Reilly and McClelland, 1994; Rolls and Kesner,
2006).
Put into a computational perspective that has attracted
considerable attention in recent years, the DG is critical for
‘‘pattern separation.’’ Pattern separation, as related to the DG,
can be described as recoding cortical input information into a
sparse, essentially orthogonal representation (McNaughton
and Morris, 1987; Treves and Rolls, 1992).
Bymanipulating the rate of adult neurogenesis, several groups
of researchers have shown by ablating or overexpressing adult
neurogenesis that newborn neurons are critical for making fine
discriminations between neighboring spatial locations or highly
similar environments in tests that reflect many of the computa-
tional characteristics of pattern separation (Clelland et al.,
2009; Creer et al., 2010; Gu et al., 2012; Nakashiba et al.,
2012; Sahay et al., 2011).594 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.Together, these studies support the idea that a DG network
dominated by young GCs is biased toward interpreting similar
but not identical inputs as distinct, whereas older GCs are biased
toward interpreting similar inputs as equivalent. While adult neu-
rogenesis in the DG is now generally accepted to occur in all
adult mammals, there are many mechanistic details about how
it takes place that will need to be determined before we have a
more complete understanding of its functional contribution
to hippocampus-mediated behaviors. That said, we need to
know a lot more about how hippocampal circuitsmediate behav-
iors, and it is likely that understanding more about adult neuro-
genesis will contribute to a better understanding of hippocampal
function.
III. Reprogramming as a Path to Human NSCs and
Neurons
The field of stem cell biology changed forever when Takahashi
and Yamanaka (Takahashi and Yamanaka, 2006) developed a
simple and repeatable method to dedifferentiate mouse somatic
cells (fibroblasts initially) to embryonic-like cells, termed induced
pluripotent stem cells (iPSCs), that could give rise to every cell of
the mouse body. The concept of reprogramming emerged from
the early works of Briggs and King (Briggs and King, 1952) and
Gurdon (Gurdon et al., 1958) but has become widely used as a
technique since Takahashi and Yamanaka published their
method and similar methods were shown to work for other spe-
cies, including humans (Takahashi et al., 2007). A plethora of
extensions and refinements followed, but the principle was
established that essentially all cells in our body maintain an
intrinsic plasticity for differentiating into a variety of cell types
with completely different functions. The impact of this technol-
ogy has been dramatic in all areas of biology but has been argu-
ably most dramatic in the neurosciences. While much work
remains to be done to improve and refine the technology,
attempts to apply these techniques to the clinic are already
ongoing. One could argue that it is too early to consider transla-
tional research because a much more basic understanding is
required, but some of the applied approaches are inexorably
pushing the field forward, resulting in the need for better system-
atic safety and reliability standards.
Neurological and Psychiatric Disease Modeling Using
Patient-Derived iPSCs
Techniques using human embryonic stem cells (hESCs) have
been available to researchers to develop methods for differenti-
ating these cells to functional neurons of different classes or to
overexpress mutant genes in the hESCs to model human dis-
ease (Marchetto et al., 2010b; Thomson et al., 1998). In addition,
prior to the development of iPSC technology, somatic cell
nuclear transfer (SCNT) was being applied in rare cases to study
specific diseases (Rideout et al., 2002). However, soon after
human cells were first reprogrammed (Takahashi et al., 2007),
the modeling of neurodevelopmental and neurodegenerative
diseases began in earnest, and the subsequent necessary effort
to develop reliable protocols for differentiating the immature
stem cells has progressed ever since. Neurogenetic disorders
were modeled first (Dimos et al., 2008; Lee et al., 2009; Marche-
tto et al., 2010a; Zhang et al., 2010), followed by a few examples
of sporadic and complex disorders (e.g., schizophrenia [SCHZ];
Neuron
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While these modeling efforts are quite recent, concerns remain
about the ability of reprogrammed fibroblasts to recapitulate dis-
ease phenotypes. Specifically, inadequate neuronal maturation,
synaptic deficiency, and failed connectivity have been observed
in many of the early-onset and neurodevelopmental diseases
modeled so far (examples: familial dysautonomia [FD] [Lee
et al., 2009], Rett syndrome [RTT] [Marchetto et al., 2010a; Ric-
ciardi et al., 2012], Huntington’s disease [HD] [Chae et al., 2012],
and SCHZ [Brennand et al., 2011]). It is possible that the
apparent detection of synaptic deficits is partly the result of the
types of measurements focused on so far. In neurodegenerative
diseases and proteopathies, neuronal toxicity due to increased
sensitivity to oxidative damage and proteasome inhibition seems
to be more prevalent than strictly synaptic deficits. Examples
include amyotrophic lateral sclerosis (ALS) (Mitne-Neto et al.,
2011), Parkinson’s disease (PD) (Nguyen et al., 2011), Alz-
heimer’s disease (AD) (Israel et al., 2012), and Down syndrome,
which mimics some aspects of AD (Shi et al., 2012). As the
number of patients and types of neurological diseases being
modeled increase, new patterns will emerge that could aid in
developing earlier diagnostics tools and facilitate effective drug
design. Significant interest among clinicians and the pharma-
ceutical industries has arisen as other neurological conditions
are proposed to be modeled using iPSCs. Attractive candidate
diseases include but are not restricted to bipolar disorder, major
depression, multiple sclerosis, and idiopathic autism.
Major Challenges in Modeling Neurological and
Psychiatric Disease and Tools for Addressing Them
When developing in vitro models, the main goal is to establish a
meaningful parallel between the phenotypes observed in the
dish and the disease pathology observed in vivo. An important
set of challenges that currently surround this field involves the
variability between clones and changes in clone genome and
phenotype over passage and time. Targeted genome modifica-
tion of hIPSCs using engineered constructs like zinc-finger
nucleases (ZFNs) (Kim et al., 1996; Porteus, 2010), transcription
activator-like effector nucleases (TALENs) (Bedell et al., 2012;
Christian et al., 2010) and, more recently, clustered regularly in-
terspaced palindromic repeats/CRISPR-associated (CRISPR/
Cas) system (Mali et al., 2013; Wiedenheft et al., 2012) present
promising strategies for modeling monogenic and genetically
defined disorders with reduced variability by generating isogenic
control lines harboring defined genetic alterations (Soldner et al.,
2011). For modeling sporadic diseases or complex neuropsychi-
atric disorders where there is no clear genetic etiology, the value
of these targeted genomic approaches is less clear but still likely
important. It is conceivable that identifying protocols that
generate lineage-specific cells will solve this problem by allow-
ing investigators to monitor the differentiation process more
specifically. Defining and consistently obtaining the disease-
relevant neural cells at comparable levels of maturation should
greatly reduce the phenotypic variability and highlight pertinent
disease characteristics. Assessing neuronal network connectiv-
ity formation is important for understanding neuronal communi-
cation imbalance in disease but can be a challenging task
because, as a general rule, the right subtype of neurons and
the specific maturation time are not represented in the dish atappropriate levels. To that end, designing cell-type-specific
promoters may help in generating the desired populations of
neurons that are directly involved in the disease being studied
(for example, Hb9-positive cells for diseases involving alpha
motor neurons such as ALS [Marchetto et al., 2008]). Addition-
ally, single-cell expression profiling should further clarify the
levels of population heterogeneity within in vitro cultures, and
advances in media culture platforms and automated cell pro-
cessing should provide the desired accuracy and consistency
that will be required.
For a number of neurological diseases, it remains unclear
whether the phenotypes involved in the pathology are restricted
to the neuronal population and to what extent the neighboring
cells are also playing a major role. Improving the protocols for
generation of cells present in the neuronal niche (i.e., astrocytes,
oligodendrocytes, microglia, and endothelial cells) could reveal
important disease phenotypes and contribute to the develop-
ment of alternative therapies. Refining the techniques to analyze
neuronal phenotypes will also help to detect more subtle differ-
ences. The field is driving strong interdisciplinary collaboration,
bringing together technological advancements from multiple
areas like electrical and mechanical engineering with principles
of neuroscience and stem cell biology. New engineering and
automation techniques are being applied to these types of
studies as both engineers and the biotech industry and Big
Pharma begin to explore and exploit this technology.
Finally, we posit that many of the challenges facing disease
modeling arise from the overall strategy employed. Many of the
current disease modeling studies search for differences in
gene expression generally or for basic functions that can be
measured in vitro, i.e., functions that have been hypothesized
to be correlated causally in the disease. Often these studies
are not hypothesis driven but rather depend on existing tech-
niques and the availability of somatic cells from whatever
patients are available to the researcher. Researchers are begin-
ning to work more closely with the clinicians who attend to and
treat the patients to better understand the diversity of each of
the patient populations to be studied and to obtain more
restricted populations of patients (e.g., discordant monozygotic
twins, drug-responsive versus nonresponsive cohorts, and
severity of the disease). These kinds of collaborations between
bench and bedside may not only lead to more targeted hypoth-
eses but may also assist in decreasing the variability reported for
in vitro modeling.
While engineering platforms allow the researcher precision
and control over the cellular microenvironment, in vivo transplan-
tation of stem cell-derived populations of human pluripotent
stem cells (hPSCs) and neurons into animal models presents a
useful way to study human development and to model disease.
Grafting NPCs at appropriate developmental stages could
potentially utilize the myriad biochemical and biophysical cues
provided in the endogenous niches to generate mature and
functional populations of the desired cells. An excellent example
is the transplantation of hPSC-derived forebrain NPCs into
the neonatal mouse brain to generate cortical neurons with spe-
cific axonal projections and dendritic patterns corresponding
to the native cortical neuron population (Espuny-Camacho
et al., 2013). In addition, transplantation of hPSC-derived medialNeuron 80, October 30, 2013 ª2013 Elsevier Inc. 595
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Perspectiveganglionic eminence (MGE) progenitors into the rodent brain
produced GABAergic interneurons with mature physiological
properties along an intrinsic timeline that mimics the endoge-
nous human neural development (Nicholas et al., 2013). This
emerging sector of stem cell biology has brought basic cell
and molecular biologists together with engineers, clinicians,
and large and small biotech companies. The new model organ-
ism is the human, and while this is a new field with plenty of ca-
veats and unknowns, it is likely to stay around for the foreseeable
future (Lancaster et al., 2013).
IV. Applications of NSC to Disease and Therapy
Human NSC Transplantation in Clinical Trials
The discovery of the existence of NSCs throughout life in animals
and then in humans led to rapid recognition of the therapeutic
potential of these cells. Fetal human NSCs are an abundant
source of neurons, astrocytes, and oligodendrocytes, with
potential application to a variety of neurological conditions.
Companies that were formed around the concept of transplant-
ing human NSCs began the groundbreaking work of making clin-
ical trials possible. Stem Cells, Inc. paved the way, generating
clinical-grade banks of purified, fetal-derived human NSCs that
are currently in use in clinical trials. They are being tested in
patients with Pelizaeus-Merzbacher disease, a demyelinating
condition of children that results in neurological dysfunction
and death; the 2-year follow-up report indicates safety and
improved and long-term myelination. These cells are also being
tested in phase I/II clinical trials for spinal cord injury and the
retinal disease dry age-related macular degeneration (AMD). In
the latter case, human NSCs are not contemplated to replace
the retinal pigment epithelial (RPE) cells that degenerate in
AMD, as they do not generate that specific lineage but rather
to substitute key RPE functions such as cytokine production
and phagocytosis. Others pursuing the clinical application of
human fetal NSCs include NeuralStem and the Azienda Ospeda-
liera Santa Maria, Terni, Italy. Both organizations are pioneering
human fetal NSC transplants for ALS patients. Although it is early
days, results thus far using well-defined human NSC products
indicate that they can be transplanted safely and will integrate
and generate long-lived progeny in their host. In contrast, the
shocking report of tumor formation seen in a young Ataxia Telan-
giectasia patient given multiple mixed fetal human CNS grafts
(Amariglio et al., 2009) cautions against the use of these cells
outside of a clinical trial; furthermore, the disease indication
should be carefully considered and tested in appropriate animal
models to provide preliminary proof of concept and safety data
before moving into humans. Given the rapid progress in pluripo-
tent stem cell production of different neural lineages, one might
ask whether fetal human NSC transplantation will at some point
be superseded. The answer will depend on the relative safety
profile of these different cell products and their ability to integrate
and mature appropriately to provide efficacy. The next two
decades will be revealing in this regard, and progress will be
eagerly watched by patients and families afflicted by neurolog-
ical disorders that could benefit from such transplants. Emphasis
should be on performing well-designed clinical trials, and the
NSC field must help educate patients to reduce the trafficking
of unproven therapies.596 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.PharmaNutri-Neurogenesis?
NSCs exist throughout life in the hippocampal DG, but human
VZ-SVZ stem cells stop actively generating neurons at about
2 years of age (Sanai et al., 2011). Adult hippocampal NSCs
have life-long activity but their numbers decline in aging and
are dramatically reduced in AD (Haughey et al., 2002), contrib-
uting to learning and memory deficits. Accumulated evidence
that adult NSCs are responsive to environmental stimuli sug-
gests ways to protect the activity of these cells, changing
behavior and nutrition to enhance life-long NSC health. Psychiat-
ric drugs can impact adult neurogenesis (Malberg et al., 2000),
and small molecules could be designed more specifically for
this target cell. Screening drugs for an impact on NSC function
can help reduce toxicity and negative effects, such as the ‘‘che-
mobrain’’ side effects of some anticancer drugs (ElBeltagy et al.,
2010). Growth factors that maintain NSC function are being
explored as supplements, including infusion of IGF1, FGF,
growth hormone, melatonin, and the BMP inhibitor Noggin
(Bonaguidi et al., 2008), and the dramatic revitalization of aged
hippocampal function demonstrated, for example, by loss of
the Wnt inhibitor DKK1 (Seib et al., 2013) suggests that this will
be a promising area for future translation.
Utilizing Neural Progenitor Heterogeneity
One particularly impressive example of the benefit of under-
standing progenitor heterogeneity is the progress made in
treating childhood brain cancers. Comparison of in-depth
gene expression analysis of normal murine progenitor cells
and gene expression analyses of pediatric brain tumors has
enabled the subdivision of medulloblastoma and ependymoma
into different classes (Gibson et al., 2010; Johnson et al., 2010),
providing more targeted therapies with better outcomes. In the
future, a more complete understanding of human CNS progen-
itor subclasses will help to identify the cells responsible for
different facets of neurological diseases and to target cell sub-
sets more precisely to either enhance or diminish a particular
cell group.
Clinical Applications of Progenitor Cell Migration
The long migrations of NSC progeny in vivo demonstrate that
CNS cells have an astonishing capability to move about the ner-
vous system. Receptor cytokines such as CXCR4-SDF1 guide
normal migration and can be activated after trauma, e.g., in
ischemic conditions, drawing cells out of adult germinal zones
toward injured sites (Robin et al., 2006). While normal SVZ cells
do not survive after attraction to these ischemic locations, it is
possible that utilizing such homing mechanisms will help target
therapeutic cells. One ongoing clinical trial utilizes the ability of
immortalized NPCs to home to tumor sites; the cells are engi-
neered to secrete a product that is activated once the cells reach
glioblastoma lesions (Aboody et al., 2013). The powerful migra-
tory ability of ventral forebrain-derived GABAergic neurons is
being explored in translational studies that aim to deliver these
cells therapeutically, anticipating that they will migrate and incor-
porate to dampen hyperexcitable states, for example, in epilepsy
and spinal neuropathic pain (Bra´z et al., 2012; Maisano et al.,
2009). One of the most astonishing examples of human NSC
progeny migration is illustrated by human glial restricted precur-
sors. When implanted into the shiverer demyelination mouse
model, these cells produced oligodendrocytes that spread
Neuron
Perspectivethroughout the nervous system and essentially replaced the
murine with human myelin (Windrem et al., 2008). Harnessing
the mechanisms of neural migration will be valuable for more
precise cell targeting and also to inhibit brain tumor-initiating
stem cell spread.
Enter Pluripotent Stem Cell-Derived NSCs
Over the past 10 years, researchers have shown that the
morphogenic gradients conceptualized and demonstrated in
animal neurodevelopment are evolutionarily maintained and
applicable to drive differentiation of diverse neural progeny
from hPSCs. Stellar examples are the production of spinal motor
neurons (Dimos et al., 2008; Wichterle et al., 2002) and midbrain
substantia nigra dopaminergic (dA) neurons (Kriks et al., 2011).
The story behind production of the latter cells underscores
how critical it is to know the normal ontogeny. Dopaminergic
cells were first derived from hPSCs by producing forebrain
progenitors and then repatterning them to midbrain, but the re-
sulting neurons largely lacked key markers of the midbrain A9
location desired for PD applications and were found to be unsta-
ble after transplantation into animal models. Instead, reiteration
of the normal developmental track discovered in mouse, by first
producing midbrain floor plate cells using high concentrations
of SHH and then differentiating these into neurons, produced
significantly more A9 dA neurons that were then shown to be sta-
ble and efficacious in animal models, providing the key proof of
concept to move toward a clinical trial (Fasano et al., 2010; Kriks
et al., 2011). While protocols for producing a diverse array of
neural cells, both central and peripheral, are being developed,
production of retinal cells has advanced, and subretinal trans-
plantation of hESC-derived RPE cells for blindness disorders
such as AMD is already in early phase clinical trials.
The ability to produce awealth of cell types from hPSCs for cell
replacement and other potential therapies such as growth fac-
tors or drug delivery is undoubtedly exciting. One outstanding
issue that has already been discussed, but worth noting again
in this context, is that we still need to understand how to mature
human NSC products appropriately. Our current approaches,
which recapitulate early developmental morphogenic stimuli,
are excellent at making early-stage cells, but many of the cell
products remain immature, indicating that signals that normally
extend development are lacking. Defining the stages and pro-
cesses along the maturation arc is important, as these impact
the ability of cells to integrate, migrate, and properly adopt
desired characteristics, as seen for oligodendrocyte and photo-
receptor transplantation (MacLaren et al., 2006; Warrington
et al., 1993).
If pluripotent cell-derived products are proven stable, safe,
and efficacious when implanted into the human CNS, we can
envision increasingly complex transplants, including not just
RPEs but also photoreceptors, organoid-derived neural struc-
tures, or even 3D, tissue-printed personalized tissue grafts.
The combination of engineering and stem cell research is power-
ful. Neural tissues that can self-assemble or be engineered from
stem cells (Aoki et al., 2009; Eiraku et al., 2011; Kawamorita
et al., 2002; Lancaster et al., 2013; Meyer et al., 2011) have a
promising future to model complex, multicell neural diseases
and as a basis for toxicity testing and mechanistic studies. The
enormous advantage of having human neural cells widely avail-able is something we could only dream about 25 years ago, and
we predict that they will prove even more valuable and will likely
supplant animal testing in efficacy studies, which have failed to
model many human diseases; however, there is much work
ahead to achieve this worthwhile goal.
Given the rapid upward trajectory of biotechnological and
biomedical advances, we can afford to let our imaginations
range: will biological devices that incorporate cells and materials
be developed, for example, as retinal prostheses or treatments
for epilepsy or PD? Will we be protected by bioengineered
sensors that use neural and computer elements, a ‘‘canary on
a chip,’’ to detect stroke or external toxins? The future for the
next generation of NSC researchers and for NSC translation is
bright.
Conclusion
Thanks to great strides in our ability to observe and study
germinal cells, and to investigate howneurons andglia are gener-
ated at cellular and molecular levels, we now have an impressive
body of knowledge concerning NSC biology. Many of the foun-
dational problems concerning NSCs were soluble only after a
specific tool was developed (Table 1) and, with the extraordinary
blossoming of technologies that is currently ongoing (Table 2),
much more information is anticipated concerning the wealth
of NSC types and their regulation. As imaging technologies
advance, we should make significant headway in understanding
howNSCs behavewithin endogenous niches and after implanta-
tion in vivo. Animal studies, notably inmouse,will continue to pro-
vide pioneering advances, especially to test application of new
tools, but increasingly, we see the field moving toward pursuing
the study of human NSC biology. The astonishing success of re-
programming somatic cells into neuronal and glial progeny with
just a handful of genes (Najm et al., 2013; Vierbuchen et al.,
2010) has made almost any cellular change seem possible, and
the more we know about how NSCs tick, the better chance we
have to produce, on demand, bona fide human neurons and
glia for a multitude of in vivo and ex vivo applications.
Overall, it has been inspiring to witness the extraordinary
growth of knowledge in this area and to contribute to what is
now an established field of NSC research, with great potential
for advancing our understanding and healing of that most intri-
cate organ, the nervous system.
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